Saturday 17 October 2026
Export OSUR’s income statement to Excel — free account
OraSure Technologies, Inc.
OSUR Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.61
0.20
−5.25%
Follow OSUR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 3 | 3 | 4 |
| (15.30%) | (18.30%) | (21.16%) | (14.07%) | ||
| (13.58%) | (15.57%) | (17.94%) | (12.20%) | ||
ROIC |
(27.59%) | (31.75%) | (35.48%) | (21.46%) | |
Return on Tangible Assets |
(21.24%) | (26.30%) | (32.00%) | (20.78%) | |
Average Days of Receivables |
70.56 | 70.46 | 85.31 | 88.84 | |
Free Cash Flow per Share |
(0.59) | (0.72) | (0.70) | (0.71) | |
Free Cash Flow |
(42.76) | (53.22) | (48.66) | (48.83) | |
Capital Expenditures |
(2.84) | (4.20) | (5.48) | (5.95) | |
| Other line items | |||||
Cash ROIC |
(7.39%) | (9.85%) | (9.92%) | (10.21%) | |
Accounts Receivable Turnover |
4.91 | 5.00 | 4.72 | 4.22 | |
Accounts Payable Turnover |
9.40 | 9.10 | 7.08 | 8.73 | |
Inventory Turnover |
2.07 | 2.05 | 1.98 | 2.03 | |
Average Days of Payables |
30.99 | 35.62 | 59.40 | 47.50 | |
Days of Inventory on Hand |
162.75 | 169.66 | 169.37 | 170.03 | |
Tax Rate |
0.04 | 0.03 | 0.03 | 0.00 | |
Research and Development Expense of Revenue |
29.59% | 36.97% | 41.21% | 39.69% | |
Selling, General and Administrative Expense of Revenue |
61.49% | 64.16% | 65.62% | 67.73% | |
Share Based Compensation of Revenue |
9.09% | 8.82% | 9.05% | 8.32% | |
Operating CF/Net income |
0.66 | 0.71 | 0.58 | 0.87 | |
Depreciation/Fixed assets |
0.25 | 0.26 | 0.26 | 0.25 | |
Capex/Depreciation |
(0.28) | (0.41) | (0.56) | (0.62) | |
Revenue per Share |
1.72 | 1.57 | 1.62 | 1.63 | |
Operating CF per Share |
(0.55) | (0.67) | (0.62) | (0.62) | |
Capex per Share |
(0.04) | (0.06) | (0.08) | (0.09) | |
Capex to Sales |
0.02 | 0.04 | 0.05 | 0.05 |
Columns are period end dates